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Thymus-derived “natural” CD4+CD25+ reg-
ulatory T (T reg) cells have been shown to 
play a role in the control of disease in various 
models of autoimmunity, but many questions 
remain concerning their antigenic specifi  city 
as well as the qualitative and quantitative re-
quirements of antigen expression in the 
  thymus for their development (1, 2). Studies in 
double transgenic mice expressing a neo-antigen 
and a TCR specifi   c for that antigen have 
  suggested that antigen-specifi  c CD4+CD25+ 
T reg cells are selected by interaction with the 
cognate self-antigen in the thymus (3, 4). Disease-
relevant T reg cells in autoimmune diabetes 
and encephalomyelitis appear to be autoanti-
gen specifi  c (5, 6). However, the question 
whether endogenous expression of the target 
self-antigen is necessary to generate T reg cells 
capable of protecting from autoimmune  disease 
in mice with a full T cell repertoire has not yet 
been examined.
Experimental autoimmune uveitis (EAU) in 
mice is a model of human posterior uveitis that 
in the United States alone aff  ects 150,000 per-
sons annually and accounts for about 10% of 
  legal blindness (7, 8). EAU can be induced in 
many animal species by immunization with reti-
nal antigens such as interphotoreceptor   retinoid-
binding protein (IRBP) or retinal arrestin 
(retinal soluble antigen [S-Ag]) in CFA. In 
immuno  logically normal mice, EAU is a cell-
mediated, Th1-dependent disease that targets 
the neural retina where the target antigens are 
located, leading to an irreversible destruction of 
photoreceptor cells and loss of vision (9).
Despite the immune-privileged nature of 
retinal antigens, it is now known that suscepti-
bility to EAU is controlled in large part by 
  central (thymic) mechanisms (10, 11). Our 
  recent study demonstrated that these mecha-
nisms   include elimination of uveitogenic eff  ec-
tor cell clonotypes as well as generation of 
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Susceptibility to experimental autoimmune uveitis (EAU), a model for human uveitis 
  induced in mice with the retinal antigen interphotoreceptor retinoid-binding protein 
(IRBP), is controlled by “natural” CD4+CD25+ regulatory T (T reg) cells. To examine 
whether endogenous expression of IRBP is necessary to generate these T reg cells, we 
studied responses of IRBP knockout (KO) versus wild-type (WT) mice. Unexpectedly, not 
only WT but also IRBP KO mice immunized with a uveitogenic regimen of IRBP in complete 
Freund’s adjuvant (CFA) exhibited CD25+ regulatory cells that could be depleted by PC61 
treatment, which suppressed development of uveitogenic effector T cells and decreased 
immunological responses to IRBP. These EAU-relevant T reg cells were not IRBP specifi  c, as 
their activity was not present in IRBP KO mice immunized with IRBP in incomplete Freund’s 
adjuvant (IFA), lacking mycobacteria (whereas the same mice exhibited normal T reg cell 
activity to retinal arrestin in IFA). We propose that mycobacterial components in CFA 
activate T reg cells of other specifi  cities to inhibit generation of IRBP-specifi  c effector 
T cells in a bystander fashion, indicating that effective T reg cells can be antigen nonspecifi  c. 
Our data also provide the fi  rst evidence that generation of specifi  c T reg cells to a native 
autoantigen in a mouse with a diverse T cell repertoire requires a cognate interaction.
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thymic-derived CD4+CD25+ T reg cells (11). However, 
whereas that study demonstrated directly, by thymic trans-
plantation between IRBP KO and WT mice, that IRBP in 
the thymus is needed to eliminate IRBP-specifi  c  eff  ector 
cells, it did not address the question whether expression of 
IRBP is also needed to elicit the EAU-relevant T reg cells.
The present study addresses the question whether T reg 
cells that protect from IRBP-induced EAU require endog-
enous expression of IRBP. We reasoned that if this is the 
case, depletion of CD25+ cells from IRBP KO mice will 
not alter their responses to IRBP. We show here that con-
trary to this hypothesis, IRBP KO mice possess EAU-rel-
evant CD4+CD25+ T reg cells that down-regulate responses 
to IRBP and limit generation of uveitogenic T cells. These 
T reg cells do not seem to be specifi  c to IRBP. Rather, they 
seem to be T reg cells of other specifi  cities that are activated 
by microbial components present in CFA and inhibit de-
velopment of IRBP-specifi  c eff  ector T cells in a bystander 
fashion. This study also indicates that a cognate interaction 
is needed to generate antigen-specifi  c T reg cells to a native 
autoantigen from a normal, diverse T cell repertoire.
RESULTS AND DISCUSSION
Both CD25-depleted WT and KO mice immunized 
with a uveitogenic regimen of IRBP/CFA show enhanced 
responses to IRBP and enhanced ability to generate 
uveitogenic effector cells
Our previous study demonstrated that thymic expression of 
IRBP is necessary to eliminate IRBP-specifi  c uveitogenic 
eff  ector T cells, but it did not address the question whether 
it is also necessary to induce EAU-relevant T reg cells. To 
answer this question, we used IRBP KO mice that lack the 
promoter region and 81% of the coding sequence of IRBP, 
and fail to express detectable IRBP in the eye or the thymus 
(11, 12). Although the IRBP KO mice are unable to de-
velop EAU, having no target antigen in the retina, they de-
velop robust antigen-specifi   c responses and their primed 
cells can transfer EAU into IRBP-suffi   cient recipients (11). 
We hypothesized that if endogenous IRBP is needed to gen-
erate EAU-relevant T reg cells, depletion of CD25+ cells 
from IRBP-defi  cient mice will fail to alter their IRBP-
  specifi  c immune responses or their ability to generate uveito-
genic eff  ector T cells.
IRBP KO and WT mice were depleted, or not, of T reg 
cells by two infusions of the PC61 mAb as described in Ma-
terials and methods, and were immunized with a uveitogenic 
regimen of IRBP in CFA. The results showed that CD25 
depletion enhanced IRBP-specifi  c delayed-type hypersensi-
tivity (DTH) responses as well as proliferation of splenocytes 
to IRBP in IRBP KO mice at least as strongly or more than 
in WT mice (Fig. 1). The greater enhancement of prolifera-
tive response in the KO might be due to an expanded reper-
toire of eff  ector T cells present in KO mice compared to WT 
(11), resulting in stronger responses after T reg cells are re-
moved. In addition, after CD25 depletion in WT as well as 
in KO mice, proinfl  ammatory cytokines (IFN-γ, TNF-α, 
IL-2, and IL-6) were increased in supernatants of IRBP-
stimulated cell cultures (not depicted). These results suggested 
that regulatory cells that could control the anti-IRBP re-
sponse were present in IRBP KO donors.
We next examined the eff   ect of CD25 depletion on 
EAU. CD25 depletion reproducibly enhanced EAU severity 
in WT mice (Fig 2, a and c; P < 0.009; reference 11). EAU 
development in CD25-depleted IRBP KO cannot be tested 
directly because these mice lack the target antigen in the ret-
ina. To be able to use clinical uveitis as readout, we per-
formed an adoptive transfer of primed lymphoid cells from 
depleted or nondepleted KO mice into naive WT recipients 
that would provide the essential retinal target. Adoptively 
transferred T cells from IRBP KO donors, depleted of 
CD25+ cells and primed with IRBP, elicited higher disease 
than did parallel cells from nondepleted donors, again sug-
gesting that an EAU-relevant regulatory cell had been re-
moved (Fig. 2 b; P < 0.004).
Immunization in IFA reveals differences in responses 
to IRBP after CD25 depletion between WT and KO mice
We considered several explanations for the presence of EAU-
relevant T reg cells in IRBP KO mice. Residual expression 
of an IRBP fragment in IRBP KO mice, which are deleted 
for the promoter region and 81% of the IRBP sequence, has 
largely been excluded. Neither we nor others were able to 
demonstrate IRBP protein in IRBP KO mice using potent 
polyclonal antibodies, nor do they develop signs of ocular 
Figure 1.  CD25-depleted WT and KO mice immunized with IRBP/
CFA show enhanced antigen-specifi  c immunological responses. Mice 
depleted of CD25+ cells by treatment with PC61 on days −10 and −7 
were immunized with IRBP in CFA on day 0. Immunological responses 
were determined 12 d after immunization. *, P < 0.05. (a and c) DTH 
  responses as specifi  c increment in ear thickness; (b and d) specifi  c prolif-
eration to IRBP of splenocytes as counts per minute of [3H]thymidine 
after subtraction of background (between 1,000 and 3,000 counts, 
  depending on group). Proliferation of lymph node cells was similarly 
  increased compared with nondepleted control mice (not depicted). Data 
from a representative experiment with fi  ve mice per group are shown.JEM VOL. 203, April 17, 2006  853
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  infl   ammation after immunization with IRBP at any dose 
(11, 12). To date, no cross-reactive antigen to IRBP has been 
identifi  ed. Although there are other retinoid-binding pro-
teins in the body, they are structurally distinct from IRBP 
and are not known to be immunologically cross-reactive. 
A more plausible possibility appeared to be that T reg cells 
relevant to EAU might be elicited by component(s) of CFA, 
which is used to stimulate innate responses and promote the 
Th1 adaptive immunity needed for EAU induction, either 
through a mimic antigen or nonspecifi  cally. We therefore 
examined whether T reg cells able to inhibit immunological 
and immunopathogenic responses to IRBP can be demon-
strated in IRBP KO mice in the absence of CFA.
IRBP KO and WT mice were immunized with 150 μg 
IRBP in IFA as described in Materials and methods. This im-
munization regimen elicits robust immunological responses 
to IRBP but is not uveitogenic. When immunized with 
IRBP/IFA, only the depleted WT mice exhibited enhanced 
DTH and lymphocyte proliferative responses to IRBP, 
whereas the depleted KO mice had unchanged DTH and 
their proliferative response to IRBP, if anything, was even 
decreased (Fig. 3). These results suggested that IRBP-specifi  c 
T reg cells were present only in WT mice. We interpret the 
reduced proliferative response to IRBP in CD25-depleted 
KO mice as elimination of IRBP-specifi  c eff  ector cells, 
which could be observed only in the absence of T reg cells, 
whose depletion would normally be dominant in eff  ect and 
mask some parallel depletion of eff  ector activity. Importantly, 
the defect in T reg cell generation appeared to be restricted 
only to IRBP, as IRBP KO mice generated antigen-specifi  c 
T reg cells to retinal S-Ag (arrestin) (Fig. 3, e and f ).
Although immunization with IRBP in IFA does not elicit 
EAU, and primed T cells from IRBP/IFA-immunized do-
nors do not transfer disease, addition of recombinant IL-12 
to the in vitro culture with IRBP can convert IRBP/IFA-
primed T cells to a Th1-polarized, uveitogenic phenotype 
(13). This provided an approach to examine whether CD25 
depletion permits enhanced generation of EAU-relevant 
  eff  ector T cells in IRBP KO mice in the absence of CFA. 
Figure 2.  IRBP KO mice have CD25+ EAU-relevant T reg cells. 
(a) EAU in WT mice is enhanced by depletion of CD25+ cells. CD25 depletion 
and IRBP immunization were as described in the legend to Fig. 1. Disease 
was scored by funduscopy 21 d after immunization. Incidence is shown 
as positive/total above each column. EAU was signifi  cantly enhanced by 
CD25 depletion *, P < 0.0002. Data pooled from two repeat experiments 
are shown. (b) EAU is enhanced in recipients of primed T cells from 
CD25-depleted IRBP KO mice. Naive WT mice were infused with 10 × 106 
antigen-activated lymphoid cells from IRBP KO mice that had been 
  depleted or not of CD25+ cells and immunized with IRBP in CFA. EAU 
in recipients was scored by funduscopy 14 d after transfer. Incidence is 
shown as positive/total. Disease was signifi  cantly enhanced by CD25 
depletion of donors (P < 0.004). Data pooled from two repeat experi-
ments are shown. (c) Representative retinal histology of mice from panel a. 
Note much more severe destruction of the retinal architecture in 
CD25-depleted mice.
Figure 3.  CD25-depleted IRBP KO mice immunized in IFA fail to 
up-regulate responses to IRBP, but do up-regulate responses to S-Ag. 
Depletion and immunization were as described in the legend to Fig. 1, ex-
cept that IRBP (a–d) and S-Ag (e and f) were injected in IFA. (a and c) Spe-
cifi  c DTH to IRBP as increment in ear thickness; (b and d) lymphocyte 
proliferation to IRBP after subtraction of background (500 to 2,500 counts, 
depending on group); (e and f) DTH and lymphocyte proliferation to reti-
nal S-Ag. All graphs are from a representative experiments with fi  ve mice 
per group. n.s., not signifi  cant.854  ANTIGEN SPECIFICITY OF T REG CELLS IN EAU | Grajewski et al.
We cultured spleen and lymph node cells from IRBP/IFA-
immunized, CD25-depleted or nondepleted IRBP KO mice 
with IRBP and IL-12, and infused them into naive WT re-
cipients. In contrast to the situation after IRBP/CFA immu-
nization, the recipients did not develop enhanced EAU, again 
indicating that EAU-relevant T reg cells are not generated by 
IRBP KO mice in the absence of CFA (Fig. 4).
Only WT mice have transferable T reg cells 
that suppress development of IRBP-specifi  c 
effector responses in IRBP KO recipients
To directly confi  rm absence of an IRBP-specifi  c T reg cell 
population in IRBP KO mice, we infused IRBP KO recipi-
ents with T reg cells purifi  ed from either naive WT or naive 
KO donors, and immunized the recipients with IRBP in IFA. 
As predicted, only WT T reg cells, but not KO T reg cells, 
were able to signifi  cantly reduce the response to IRBP of 
  recipient KO mice (Fig. 5, a and c). Lymphoid cells from 
these primary recipients were then transferred to WT sec-
ondary recipients (after in vitro activation with IRBP plus 
IL-12) to examine generation of EAU-relevant eff  ector 
T cells. The IRBP-stimulated cells from primary recipients of 
WT T reg cells induced signifi  cantly less disease in the sec-
ondary recipients than did cells from primary recipients of 
KO T reg cells, or from KO donors that did not receive any 
T reg cells, indicating that WT T reg cells, but not KO T reg 
cells, were able to inhibit eff  ector generation in the primary 
recipients (Fig. 5, b and d).
In the aggregate, these results support the notion that the 
EAU-relevant T reg cells generated by IRBP KO mice im-
munized in the presence of CFA are not IRBP specifi  c. We 
consider the presence of a mimic antigen in CFA as unlikely 
because immunization of WT mice with CFA alone does not 
result in EAU (unpublished data). Our data do not distinguish 
whether the T reg cells in question recognize mycobacterial 
antigens or whether these are T reg cells of undetermined 
specifi   city directly activated through Toll-like receptors 
(which is our preferred interpretation). T reg cells that con-
trol responses to microbes as well as direct activation of T reg 
cells through Toll-like receptors have been demonstrated in 
other models (14, 15), so both mechanisms may be at play.
Although our study does not directly address the site of 
action of the T reg cells, we hypothesize that the CFA-elicited 
T reg cells, which lack their corresponding stimulus in the 
eye, might act primarily in the periphery to limit generation of 
eff  ector T cells elicited by immunization. In contrast, IRBP-
specifi  c T reg cells (and perhaps T reg cells specifi  c to other 
self-tissue components), which have a corresponding antigenic 
trigger in the eye, might also act to inhibit their action in the 
eye. These questions will be addressed in a separate study.
We speculate that our data could also help to explain the 
well-known but poorly understood protective eff  ects of CFA 
and pertussis administered before induction of autoimmunity 
(16). It is conceivable that pretreatment with these bacterial 
components generates regulatory cells, which, upon reexpo-
sure to the same microbial stimulus in emulsion with antigen, 
inhibit generation of autopathogenic eff   ector cells in a 
  bystander fashion.
It is also important to emphasize that our data provide the 
fi  rst direct evidence of a requirement for the cognate antigen 
to generate specifi  c T reg cells in a natural system comprising 
a native autoantigen and a diverse T cell repertoire. Thus far, 
evidence for this was wholly based on experiments in double 
transgenic mice expressing a T cell receptor and a neo–self-
antigen, where both the eff  ector and the regulatory cells bear 
the same T cell receptor (which is not what is believed to 
  occur in the genetically unmanipulated animal) (17).
Conclusions
This study provides evidence that generation of T reg cells 
to IRBP, a native autoantigen in a normal mouse with a 
Figure 4.  CD25 depletion does not enhance generation of IRBP-
specifi  c uveitogenic precursors in IRBP KO mice immunized with 
IRBP/IFA. Naive WT mice were infused with 5 × 106 activated lymphoid 
cells from IRBP KO mice that had been depleted or not of CD25+ cells and 
immunized with IRBP/IFA. Donor cells were cultured before transfer with 
IRBP and 50 ng/ml IL-12 for 72 h. Funduscopy scores + standard error of 
WT recipients 14 d after adoptive transfer are shown. Combined data 
from two repeat experiments are shown.
Figure 5.  CD25+ cells from WT mice, but not IRBP KO mice, sup-
press IRBP-specifi  c immune responses in KO recipients immunized 
with IRBP/IFA. IRBP KO mice were infused with 2–2.5 × 106 CD4+CD25+ 
T reg cells from WT or KO donors and were immunized with IRBP/IFA on 
day 0. Immunological assays were performed as described in Materials 
and methods. Two repeat experiments are shown. (a and c) DTH responses; 
(b and d) EAU in secondary (WT) recipients of IRBP-stimulated cells from 
mice in panels a and c, respectively (funduscopy scores + standard error 
14 d after adoptive transfer). *, P < 0.05.JEM VOL. 203, April 17, 2006  855
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diverse T cell repertoire, requires a cognate interaction. This 
contrasts with a lack of requirement for expression of this 
antigen to positively select eff  ector T cells (11). Neverthe-
less, although endogenous expression of IRBP is needed to 
generate IRBP-specifi  c T reg cells, EAU-relevant T reg cells 
do not have to be IRBP specifi  c. We propose that these 
are T reg cells activated by microbial components present 
in CFA that inhibit development of IRBP-specifi  c eff  ec-
tor T cells in an antigen-nonspecifi  c bystander fashion. This 
kind of mechanism could be relevant not only to autoimmune 
uveitis, but also to other autoimmune diseases in humans, 
which often are thought to be triggered by microbial in-
fections, possibly combining a mimic antigen and an innate 
stimulus promoting tissue-destructive cellular immunity. 
Our data show that (a) pathogenic autoimmunity can be 
controlled in a bystander fashion by T reg cells that do not 
recognize the target antigen, and (b) that the same adjuvant 
eff  ect needed to elicit EAU also activates T reg cells that help 
control the disease. Therefore, we propose to extend the 
concept of CD4+CD25+ T reg cells as a protective shield 
against   autoimmunity that incorporates a broad basis, including 
self- as well as microbial components.
MATERIALS AND METHODS
Animals. B10.RIII mice (H-2r) were purchased from The Jackson Labora-
tory. IRBP KO mice lacking the promotor region and 81% of the IRBP 
coding sequence were generated as described previously (12) and back-
crossed onto the B10.RIII background for 10 generations. Mice were used 
between 8 and 26 wk of age. All experiments were approved by an Institu-
tional Review Board.
Antigens and reagents. Native bovine IRBP was prepared as described 
previously (18–20). CFA was purchased from Difco and supplemented with 
additional Mycobacterium tuberculosis H37RA to 2.5 mg/ml. The monoclonal 
anti-CD25 antibody 7D4 (FITC-labeled) and anti-CD4 (PE-labeled) for fl  ow 
cytometry were from BD Biosciences. Monoclonal PC61 anti-CD25 anti-
bodies for in vivo use were produced in-house by collecting ascites from nude 
mice injected with the hybridoma cells, which were purchased from American 
Type Culture Collection. Bovine retinal arrestin (S-Ag) was provided by 
P. Hargrave and H. McDowell (University of Florida, Gainesville, FL).
Depletion and analysis of CD25+ cells. To deplete CD25+ cells, mice 
were given two i.p. injections, 3 d apart, of 1.0 mg of the anti-CD25 mAb 
PC61 (21). 7 d after the second injection, depletion was determined by 
fl  ow cytometry in splenocytes of representative mice. At this time the mice 
were also immunized for EAU. Depletion reduced the CD4+CD25+ 
T cells in the spleen from ~10% to well under 2% on gated CD4+ cells with 
anti-CD25 mAb 7D4, which binds to a diff  erent epitope than PC61 on the 
IL-2 receptor (22).
Isolation and adoptive transfer of CD25+ cells. CD25+ T reg cells 
were isolated from lymph nodes (inguinal, iliac, axillary, mesenteric, and 
submandibular) of either naive WT or IRBP KO mice using anti–CD25-PE 
(clone 7D4) and anti-PE MicroBeads on an AutoMACS instrument (Milte-
nyi Biotec) according to manufacturer’s instructions. The purity of isolated 
CD4+CD25+ T cells was >90% as determined by fl  ow cytometry. Naive 
IRBP KO recipients were infused through the tail vein with 2–2.5 × 106 
T reg cells from either naive WT or KO donors, or they received medium 
alone (no T reg cells). The recipients were then immunized with 150 μg 
IRBP emulsifi  ed in IFA. DTH was performed on day 12, and   lymphoid cells 
were collected for adoptive transfer into WT secondary recipients as 
  described below.
Immunizations, EAU induction, and EAU scoring. Groups consisted 
of three to fi  ve mice, depending on the availability of the IRBP KO animals. 
To elicit responses to IRBP, 150 μg bovine IRBP was emulsifi  ed in IFA 1:1 
vol/vol for a total of 200 μl of emulsion injected subcutaneously, divided 
among both thighs and the base of the tail. This regimen elicits immunologi-
cal responses but is not uveitogenic. To elicit responses to S-Ag, mice were 
immunized with 200 μg bovine S-Ag in IFA. To induce EAU, mice were 
immunized with 5 μg bovine IRBP emulsifi  ed in CFA supplemented with 
M. tuberculosis H37RA to 2.5 mg/ml. This IRBP dose was determined in 
prior experiments to elicit mild to moderate EAU scores that permitted dis-
ease enhancement after CD25 depletion in B10.RIII mice. Alternatively, 
EAU was induced by adoptive transfer of cells taken from IRBP-primed do-
nors and cultured in vitro with IRBP as described previously (13). In brief, 
spleen and lymph node cells from IRBP-immunized donors were collected 
12 d after immunization and stimulated in vitro with IRBP for 72 h. 5–10 
million cultured cells were infused intraperitoneally into naive WT recipi-
ents. Disease scores were read in a masked fashion by funduscopy and con-
fi  rmed by histopathology on eyes harvested 14 d after adoptive transfer, or 
21 d after active immunization (approximately 9 d after onset). Scores were 
assigned on a scale from 0 (no infl  ammation) to 4 (complete destruction of 
the retina) in half-point increments as described previously (8).
Determination of immunological responses. IRBP- or S-Ag–specifi  c 
DTH was determined by an ear swelling assay 12 d after immunization as 
described previously (23). In brief, 10 μg IRBP or 10 μg S-Ag in 10 μl PBS 
was injected into the right ear pinna, and 10 μl PBS alone was injected into 
the left ear pinna. After 48 h, the antigen-specifi  c response was calculated by 
determining the diff  erence in thickness (μm) between the antigen- and the 
PBS-injected ears using a spring-loaded micrometer   (Mitutoya). For lym-
phocyte proliferation assay, spleens and draining lymph nodes (inguinal and 
iliac) were collected 12 d after immunization and pooled within the group. 
Proliferation was measured by [3H]thymidine uptake during the last 16 h of a 
72-h culture on triplicate cultures of 0.2 ml essentially as described previously 
(23). Lymphocytes of animals immunized with IRBP/CFA were stimulated 
with 10–30 μg IRBP, lymphocytes of mice immunized with IRBP/IFA 
were stimulated with 100 μg IRBP, and lymphocytes of animals immu-
nized with S-Ag were stimulated with 30 μg S-Ag. Cytokine responses 
were   determined using multiplex SearchLight Arrays technology (Endogen 
Chemical Co.; reference 24 and http://www.endogen.com/services).
Statistical analysis. All experiments were performed at least twice and 
were highly reproducible. Figures show data from representative experi-
ments or from combined experiments as indicated. Statistical analysis of 
EAU scores was performed using the Snedecor and Cochran z test for linear 
trend in proportions (25). This is a nonparametric, frequency-based test that 
takes into account both disease severity and incidence. DTH, lymphocyte 
proliferation, and cytokine data were analyzed using an independent t test. 
Probability values of ≤0.05 were considered to be signifi  cant and are 
  depicted as asterisks in the Figures.
We thank Drs. Paul Hargrave and Hugh McDowell from the University of Florida 
(Gainesville, FL) for providing the retinal S-Ag (arrestin).
This study was supported by NIH Intramural funding. R.S. Grajewski was 
supported by a grant (GR 2647/1-1) from the Deutsche Forschungsgemeinschaft. 
Generation of the IRBP KO mice (G.I. Liou) was supported by National Eye Institute 
grant EY03829.
The authors have no confl  icting fi  nancial interests.
Submitted: 25 February 2005
Accepted: 26 February 2006
R  E  F  E  R  E  N  C  E  S 
 1. Shevach, E.M. 2002. CD4+ CD25+ suppressor T cells: more ques-
tions than answers. Nat. Rev. Immunol. 2:389–400.
 2. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory T cells for im-
munologic self-tolerance and negative control of immune responses. 
Annu. Rev. Immunol. 22:531–562.856  ANTIGEN SPECIFICITY OF T REG CELLS IN EAU | Grajewski et al.
  3.  Jordan, M.S., A. Boesteanu, A.J. Reed, A.L. Petrone, A.E. Holenbeck, 
M.A. Lerman, A. Naji, and A.J. Caton. 2001. Thymic selection of 
CD4+CD25+ regulatory T cells induced by an agonist self-peptide. 
Nat. Immunol. 2:301–306.
 4. Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer. 2002. 
Origin of regulatory T cells with known specifi  city for antigen. Nat. 
Immunol. 3:756–763.
  5.  Reddy, J., Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R.A. 
Sobel, K.W. Wucherpfennig, and V.K. Kuchroo. 2004. Myelin proteo-
lipid protein-specifi  c CD4+CD25+ regulatory cells mediate genetic 
resistance to experimental autoimmune encephalomyelitis. Proc. Natl. 
Acad. Sci. USA. 101:15434–15439.
 6. Tang, Q., K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, E.L. 
Masteller, H. McDevitt, M. Bonyhadi, and J.A. Bluestone. 2004. In vi-
tro–expanded antigen-specifi  c regulatory T cells suppress autoimmune 
diabetes. J. Exp. Med. 199:1455–1465.
  7.  Gritz, D.C., and I.G. Wong. 2004. Incidence and prevalence of uveitis 
in Northern California; the Northern California Epidemiology of 
Uveitis Study. Ophthalmology. 111:491–500 (discussion 500).
  8.  Agarwal, R.K., and R.R. Caspi. 2004. Rodent models of experimental 
autoimmune uveitis. Methods Mol. Med. 102:395–420.
 9. Caspi, R.R. 1999. Immune mechanisms in uveitis. Springer Semin. 
Immunopathol. 21:113–124.
10.  Egwuagu, C.E., S. Bahmanyar, R.M. Mahdi, R.B. Nussenblatt, I. Gery, 
and R.R. Caspi. 1992. Predominant usage of V beta 8.3 T cell receptor 
in a T cell line that induces experimental autoimmune uveoretinitis 
(EAU). Clin. Immunol. Immunopathol. 65:152–160.
11. Avichezer, D., R.S. Grajewski, C.C. Chan, M.J. Mattapallil, P.B. 
Silver, J.A. Raber, G.I. Liou, B. Wiggert, G.M. Lewis, L.A. Donoso, 
and R.R. Caspi. 2003. An immunologically privileged retinal antigen 
elicits tolerance: major role for central selection mechanisms. J. Exp. 
Med. 198:1665–1676.
12. Liou, G.I., Y. Fei, N.S. Peachey, S. Matragoon, S. Wei, W.S. Blaner, 
Y. Wang, C. Liu, M.E. Gottesman, and H. Ripps. 1998. Early on-
set photoreceptor abnormalities induced by targeted disruption of 
the interphotoreceptor retinoid-binding protein gene. J. Neurosci. 
18:4511–4520.
13. Tarrant, T.K., P.B. Silver, C.C. Chan, B. Wiggert, and R.R. Caspi. 
1998. Endogenous IL-12 is required for induction and expression of 
  experimental autoimmune uveitis. J. Immunol. 161:122–127.
14.  Rouse, B.T., and S. Suvas. 2004. Regulatory cells and infectious agents: 
detentes cordiale and contraire. J. Immunol. 173:2211–2215.
15. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, 
and J. Demengeot. 2003. Regulatory T cells selectively express Toll-
like receptors and are activated by lipopolysaccharide. J. Exp. Med. 
197:403–411.
16. Ben-Nun, A., S. Yossefi  , and D. Lehmann. 1993. Protection against 
autoimmune disease by bacterial agents. II. PPD and pertussis toxin as 
proteins active in protecting mice against experimental autoimmune 
  encephalomyelitis. Eur. J. Immunol. 23:689–696.
17. Hsieh, C.S., Y. Liang, A.J. Tyznik, S.G. Self, D. Liggitt, and A.Y. 
Rudensky. 2004. Recognition of the peripheral self by naturally arising 
CD25+ CD4+ T cell receptors. Immunity. 21:267–277.
18. Lin, Z.Y., G.R. Li, N. Takizawa, J.S. Si, E.A. Gross, K. Richardson, 
and J.M. Nickerson. 1997. Structure-function relationships in interpho-
toreceptor retinoid-binding protein (IRBP). Mol. Vis. 3:17.
19. Pepperberg, D.R., T.L. Okajima, H. Ripps, G.J. Chader, and B. 
Wiggert. 1991. Functional properties of interphotoreceptor retinoid-
binding protein. Photochem. Photobiol. 54:1057–1060.
20.  Pepperberg, D.R., T.L. Okajima, B. Wiggert, H. Ripps, R.K. Crouch, 
and G.J. Chader. 1993. Interphotoreceptor retinoid-binding protein 
(IRBP). Molecular biology and physiological role in the visual cycle of 
rhodopsin. Mol. Neurobiol. 7:61–85.
21. Malek, T.R., R.J. Robb, and E.M. Shevach. 1983. Identifi  cation and 
initial characterization of a rat monoclonal antibody reactive with the 
murine interleukin 2 receptor-ligand complex. Proc. Natl. Acad. Sci. 
USA. 80:5694–5698.
22.  Lowenthal, J.W., P. Corthesy, C. Tougne, R. Lees, H.R. MacDonald, 
and M. Nabholz. 1985. High and low affi   nity IL 2 receptors: analysis by 
IL 2 dissociation rate and reactivity with monoclonal anti-receptor anti-
body PC61. J. Immunol. 135:3988–3994.
23. Silver, P.B., L.V. Rizzo, C.C. Chan, L.A. Donoso, B. Wiggert, and 
R.R. Caspi. 1995. Identifi  cation of a major pathogenic epitope in the 
human IRBP molecule recognized by mice of the H-2r haplotype. 
Invest. Ophthalmol. Vis. Sci. 36:946–954.
24. Moody, M.D., S.W. Van Arsdell, K.P. Murphy, S.F. Orencole, and 
C. Burns. 2001. Array-based ELISAs for high-throughput analysis of 
  human cytokines. Biotechniques. 31:186–190.
25. Snedecor, G.W., and W.G. Cochran. 1967. Statistical Methods. Iowa 
State University Press, Ames. 593 pp.